ASIT biotech reported the appointment of Prof. Mohamed Shamji as Scientific Advisor for the development of new drug candidates. Prof. Shamji will provide ASIT biotech's pre-clinical research teams with his support and expertise in immunology with the principal objective of characterizing the immunological properties of new drug candidates. Prof. Shamji completed his clinical scientist fellowship training in clinical immunology at the Chelsea & Westminster Hospital NHS Foundation Trust in London, United Kingdom, in 2004. He then pursued his interest in translational research and completed PhD studies in allergy and clinical immunology at the National Heart & Lung Institute, Imperial College London in 2010.